Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 1,019 | 21,792 | 0 | 0 | 0 |
| Cost of Goods | 1,686 | 5,172 | N/A | N/A | N/A |
| Gross Profit | -667 | 16,620 | N/A | N/A | N/A |
| Operating Expenses | 4,382 | 3,224 | 3,857 | 3,226 | 3,105 |
| Operating Income | -4,363 | 13,568 | -3,857 | -3,226 | -3,105 |
| Interest Expense | 200 | 200 | 197 | 196 | 194 |
| Other Income | -3,338 | -991 | 388 | 1,799 | 440 |
| Pre-tax Income | -7,901 | 12,377 | -3,666 | -1,623 | -2,859 |
| Income Tax | -697 | 634 | N/A | N/A | N/A |
| Net Income Continuous | -7,204 | 11,743 | -3,666 | -1,623 | -2,859 |
| Net Income | $-7,204 | $11,743 | $-3,666 | $-1,623 | $-2,859 |
| EPS Basic Total Ops | -0.76 | 1.18 | -0.40 | -0.08 | -0.33 |
| EPS Basic Continuous Ops | -0.74 | 1.20 | -0.38 | -0.06 | -0.31 |
| EPS Diluted Total Ops | -0.76 | 1.12 | -0.40 | -0.08 | -0.33 |
| EPS Diluted Continuous Ops | -0.74 | 1.00 | -0.38 | -0.06 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.40 | 1.12 | -0.40 | -0.14 | -0.28 |
| EBITDA(a) | $-4,280 | $13,651 | $-3,772 | $-3,136 | $-3,005 |